Gemifloxacin (LB20304;
SB265805; Factive) is a 3rd generation, orally bioavailable, and broad-spectrum quinolone antibacterial agent approved for use in the treatment of
acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate
pneumonia.
纯度:≥98%
CAS:175463-14-6